|
Parameters
|
Unadjusted mixed model analysis (all patients, n = 210), B (95% CI)
|
Adjusted mixed model analysis (all patients, n = 210), B (95% CI)
|
Adjusted mixed model analysis (patients with AS, n = 105), B (95% CI)
|
Adjusted mixed model analysis (patients with nr-axSpA, n = 95), B (95% CI)
|
|---|
|
Outcome: BASFI
|
|
Sacroiliitis sum score (0–8)
|
0.09 (-0.05 to 0.22)
|
0.10 (0.01 to 0.19)
|
0.16 (-0.03 to 0.36)
|
0.09 (-0.11 to 0.30)
|
|
mSASSS, points (0–72)
|
-
|
0.05 (0.03 to 0.07)
|
0.04 (0.02 to 0.06)
|
0.08 (0.03 to 0.14)
|
|
BASDAI, points NRS (0–10)
|
-
|
0.81 (0.74 to 0.88)
|
0.84 (0.74 to 0.93)
|
0.75 (0.63 to 0.86)
|
|
CRP, mg/l
|
-
|
0.00 (-0.01 to 0.01)
|
0.00 (-0.01 to 0.01)
|
0.00 (-0.02 to 0.01)
|
|
Male sex
|
-
|
-0.02 (-0.40 to 0.37)
|
0.03 (-0.48 to 0.55)
|
-0.13 (-0.74 to 0.48)
|
|
Outcome: BASMI
|
|
Sacroiliitis sum score (0–8)
|
0.20 (0.11 to 0.30)
|
0.12 (0.03 to 0.21)
|
0.17 (-0.02 to 0.37)
|
0.21 (0.01 to 0.40)
|
|
mSASSS, points (0–72)
|
-
|
0.07 (0.05 to 0.09)
|
0.07 (0.04 to 0.09)
|
0.04 (-0.01 to 0.10)
|
|
BASDAI, points NRS (0–10)
|
-
|
0.22 (0.15 to 0.29)
|
0.23 (0.14 to 0.32)
|
0.18 (0.07 to 0.30)
|
|
CRP, mg/l
|
-
|
0.01 (0.00 to 0.02)
|
0.01 (0.00 to 0.03)
|
0.00 (-0.03 to 0.01)
|
|
Male sex
|
-
|
0.00 (-0.39 to 0.39)
|
0.32 (-0.21 to 0.85)
|
-0.35 (-0.92 to 0.22)
|
-
mSASSS modified Stoke Ankylosing Spondylitis Spine Score, AS Ankylosing Spondylitis, nr-axSpA non-radiographic axial spondyloarthritis, BASFI Bath Ankylosing Spondylitis Functional Index, CRP C-reactive protein, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, NRS numerical rating scale, BASMI Bath Ankylosing Spondylitis Metrology Index
- Main results are marked in bold
